WASHINGTON, Dec. 11 (TNSFR) -- Hoffman-La Roche Inc., Little Falls, New Jersey, has been granted a one-year interim extension by the U.S. Department of Commerce Patent and Trademark Office for its patent, which protects the human drug product Bitopertin oral tablets, allowing the patent term to extend beyond its original expiration date of Dec. 17, 2025.

The extension was sought through a timely application filed by the company on Dec. 1, 2025. This action falls under 35 U.S.C. 156( . . .

Click here for more information about our products